Balloon catheter method for reducing restenosis via irreversible electroporation
US-10010666-B2 · Jul 3, 2018 · US
US10668208B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10668208-B2 |
| Application number | US-201815988408-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 24, 2018 |
| Priority date | Mar 27, 2008 |
| Publication date | Jun 2, 2020 |
| Grant date | Jun 2, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.
Opening claim text (preview).
That which is claimed is: 1. A balloon catheter device for insertion into a vessel and reducing neointima, comprising: a flexible elongated shaft comprising a distal end portion for insertion into a vessel; a balloon positioned at the distal end portion; a first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon; a second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow between the first and second electrodes and through vascular tissue to the first electrode, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon; wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix spanning an entire length of the balloon, and comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface; an electrical power source which provides electrical pulses to the electrodes for durations and in amounts sufficient to subject substantially all vascular cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE). 2. The device of claim 1 , wherein the first and second electrodes are formed from electrically conductive ink drawn on the balloon. 3. The device of claim 1 , wherein the device will carry out NTIRE using a voltage and a current with defined ranges over a defined period of time and in absence of drug being delivered into the vascular cells. 4. The device of claim 3 , wherein the electrical power source is designed to emit pulses wherein the pulses have a duration of from 50 to 200 microseconds. 5. The device of claim 1 , wherein the electrical power source applies current in pulses. 6. The device of claim 5 , wherein the electrical power source is configured to apply pulses having a duration of from 50 to 200 microseconds. 7. The device of claim 6 , wherein the electrical power source is configured to apply pulses of a current in a range of from 2,000 V/cm to 6,000 V/cm. 8. The device of claim 7 , wherein the electrical power source is configured to apply between two and twenty-five pulses. 9. The device of claim 8 , wherein the electrical power source is configured to apply 10 pulses for 100 microseconds each at a current of 3,800 V/cm.
with a guide wire · CPC title
Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor · CPC title
Irreversible electroporation · CPC title
Expandable means emitting energy, e.g. by elements carried thereon · CPC title
for enhancing the absorption properties of tissue, e.g. by electroporation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.